Malarone treatment failure not associated with previously described mutations in the cytochrome b gene
Open Access
- 1 January 2004
- journal article
- case report
- Published by Springer Nature in Malaria Journal
- Vol. 3 (1) , 14
- https://doi.org/10.1186/1475-2875-3-14
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Genetic Confirmation of Atovaquone-Proguanil-Resistant Plasmodium falciparum Malaria Acquired by a Nonimmune Traveler to East AfricaClinical Infectious Diseases, 2003
- Detection of atovaquone and Malarone™ resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb)Molecular and Cellular Probes, 2003
- Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reportsBMJ, 2003
- Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo : rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance markerMalaria Journal, 2003
- Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria with Artesunate‐Atovaquone‐ProguanilClinical Infectious Diseases, 2002
- Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, NigeriaMalaria Journal, 2002
- Atovaquone‐Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐Blind StudyClinical Infectious Diseases, 2001
- Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding SiteAntimicrobial Agents and Chemotherapy, 2000
- Preventing antimalarial drug resistance through combinationsDrug Resistance Updates, 1998
- Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial ParasiteJournal of Biological Chemistry, 1997